<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nitrogen (N) linked glycosylation defects</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nitrogen (N) linked glycosylation defects</h1>
<div class="graphic"><div class="figure"><div class="ttl">Nitrogen (N) linked glycosylation defects</div><div class="cntnt"><table cellspacing="0"><colgroup span="7" width="14%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Gene</td> <td class="subtitle1_left">Gene locus MIM#</td> <td class="subtitle1_left">Function</td> <td class="subtitle1_left">Localization of defect</td> <td class="subtitle1_left">Disease</td> <td class="subtitle1_left">Inheritance</td> <td class="subtitle1_left">Initial molecular characterization (PMID)</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Interconversion of monosaccharides</td> </tr> <tr> <td class="indent1">Phosphomannomutase 2 (<em>PMM2</em>)</td> <td>601785</td> <td>Phosphomannomutase (converts Man-6-P to Man-1-P)</td> <td>Cytosol</td> <td>PMM2-CDG (CDG-Ia)</td> <td>AR</td> <td>9140401</td> </tr> <tr> <td class="indent1">Mannose phosphate isomerase (<em>MPI</em>)</td> <td>154550</td> <td>Phosphomannose isomerase (converts Fru-6-P to Man-6-P)</td> <td>Cytosol</td> <td>MPI-CDG (CDG-Ib)</td> <td>AR</td> <td>9525984</td> </tr> <tr> <td class="subtitle2_left" colspan="7">N-glycan lipid-linked oligosaccharide assembly</td> </tr> <tr> <td class="indent1">Dolichyl-phosphate N-acetylglucosaminephosphotransferase 1 (<em>DPAGT1</em>)</td> <td>191350</td> <td>GlcNAc-1-P transferase (transfers 1<sup>st</sup> GlcNAc)</td> <td>ER (cytosolic side)</td> <td>DPAGT1-CDG (CDG-Ij); CMS13</td> <td>AR</td> <td>12872255</td> </tr> <tr> <td class="indent1">ALG13 UDP-N-acetylglucosaminyltransferase subunit (<em>ALG13</em>)</td> <td>300776</td> <td>UDP-GlcNAc transferase (transfers 2<sup>nd</sup> GlcNAc)</td> <td>ER (cytosolic side)</td> <td>ALG13-CDG (CDG-Is) in males; EIEE36 in females</td> <td>XL</td> <td>22492991</td> </tr> <tr> <td class="indent1">ALG14 UDP-N-acetylglucosaminyltransferase subunit (<em>ALG14</em>)</td> <td>612866</td> <td>UDP-GlcNAc transferase (transfers 2<sup>nd</sup> GlcNAc)</td> <td>ER (cytosolic side)</td> <td>CMS15</td> <td>AR</td> <td>23404334</td> </tr> <tr> <td class="indent1">ALG1 chitobiosyldiphosphodolichol beta-mannosyltransferase (<em>ALG1</em>)</td> <td>605907</td> <td>Beta 1-4 Man-transferase (transfers 1<sup>st</sup> mannose)</td> <td>ER (cytosolic side)</td> <td>ALG1-CDG (CDG-Ik)</td> <td>AR</td> <td>14709599, 14973778, 14973782</td> </tr> <tr> <td class="indent1">ALG2 alpha-1,3/1,6-mannosyltransferase (<em>ALG2</em>)</td> <td>607905</td> <td>Alpha 1-3/6 Man-transferase (transfers 2<sup>nd</sup> and 3<sup>rd</sup> mannoses)</td> <td>ER (cytosolic side)</td> <td>ALG2-CDG (CDG-Ii); CMS14</td> <td>AR</td> <td>12684507</td> </tr> <tr> <td class="indent1">ALG11 alpha-1,2-mannosyltransferase (<em>ALG11</em>)</td> <td>613666</td> <td>Alpha 1-2 Man-transferase (transfers 4<sup>th</sup> and 5<sup>th</sup> mannoses)</td> <td>ER (cytosolic side)</td> <td>ALG11-CDG (CDG-Ip)</td> <td>AR</td> <td>20080937</td> </tr> <tr> <td class="indent1">RFT1 homolog (<em>RFT1</em>)</td> <td>611908</td> <td>Man5GlcNAc2-PP-Dol flippase</td> <td>ER</td> <td>RFT1-CDG (CDG-In)</td> <td>AR</td> <td>18313027</td> </tr> <tr> <td class="indent1">ALG3 alpha-1,3- mannosyltransferase (<em>ALG3</em>)</td> <td>608750</td> <td>Alpha 1-3 Man-transferase (transfers 6<sup>th</sup> mannose)</td> <td>ER (luminal side)</td> <td>ALG3-CDG (CDG-Id)</td> <td>AR</td> <td>10581255</td> </tr> <tr> <td class="indent1">ALG9 alpha-1,2-mannosyltransferase (<em>ALG9</em>)</td> <td>606941</td> <td>Alpha 1-2 Man-transferase (transfers 7<sup>th</sup> and 9<sup>th</sup> mannoses)</td> <td>ER (luminal side)</td> <td>ALG9-CDG (CDG-IL); Gillessen-Kaesbach-Nishimura syndrome</td> <td>AR</td> <td>15148656</td> </tr> <tr> <td class="indent1">ALG12 alpha-1,6-mannosyltransferase (<em>ALG12</em>)</td> <td>607144</td> <td>Alpha 1-6 Man-transferase (transfers 8<sup>th</sup> mannose)</td> <td>ER (luminal side)</td> <td>ALG12-CDG (CDG-Ig)</td> <td>AR</td> <td>11983712</td> </tr> <tr> <td class="indent1">ALG6 alpha-1,3-glucosyltransferase (<em>ALG6</em>)</td> <td>604566</td> <td>Alpha 1-3 Glc-transferase (transfers 1<sup>st</sup> glucose)</td> <td>ER (luminal side)</td> <td>ALG6-CDG (CDG-Ic)</td> <td>AR</td> <td>10359825</td> </tr> <tr> <td class="indent1">ALG8 alpha-1,3-glucosyltransferase (<em>ALG8</em>)</td> <td>608103</td> <td>Alpha 1-3 Glc-transferase (transfers 2<sup>nd</sup> glucose)</td> <td>ER (luminal side)</td> <td>ALG8-CDG (CDG-Ih)</td> <td>AR</td> <td>12480927</td> </tr> <tr> <td class="subtitle2_left" colspan="7">Glycan transfer to nascent protein</td> </tr> <tr> <td class="indent1">Tumor suppressor candidate 3 (<em>TUSC3</em>)</td> <td>601385</td> <td>OST subunit</td> <td>ER</td> <td>TUSC3-CDG (MRT7/MRT22)</td> <td>AR</td> <td>18455129, 18452889</td> </tr> <tr> <td class="indent1">Dolichyl-diphosphooligosaccharide protein glycosyltransferase noncatalytic subunit (<em>DDOST</em>)</td> <td>614507</td> <td>OST subunit</td> <td>ER</td> <td>DDOST-CDG (CDG-Ir)</td> <td>AR</td> <td>22305527</td> </tr> <tr> <td class="indent1">STT3 oligosaccharyltransferase complex catalytic subunit A (<em>STT3A</em>)</td> <td>601134</td> <td>OST subunit</td> <td>ER</td> <td>SST3A-CDG (CDG-Iw)</td> <td>AR</td> <td>23842455</td> </tr> <tr> <td class="indent1">STT3 oligosaccharyltransferase complex catalytic subunit B (<em>STT3B</em>)</td> <td>608605</td> <td>OST subunit</td> <td>ER</td> <td>SST3B-CDG (CDG-Ix)</td> <td>AR</td> <td>23842455</td> </tr> <tr> <td class="indent1">Oligosaccharyltransferase complex noncatalytic subunit (<em>OSTC</em>)</td> <td>619023</td> <td>OST subunit</td> <td>ER</td> <td>OSTC-CDG</td> <td>AR</td> <td>32267060</td> </tr> <tr> <td class="indent1">Magnesium transporter 1 (<em>MAGT1</em>)</td> <td>300715</td> <td>OST subunit</td> <td>ER</td> <td>XMEN</td> <td>XL</td> <td>21796205</td> </tr> <tr> <td class="indent1">Signal sequence receptor subunit 3 (<em>SSR3</em>)</td> <td>606213</td> <td>Translocon-associated protein, gamma subunit</td> <td>ER</td> <td>SSR3-CDG</td> <td>AR</td> <td>30945312</td> </tr> <tr> <td class="indent1">Signal sequence receptor subunit 4 (<em>SSR4</em>)</td> <td>300090</td> <td>Translocon-associated protein, delta subunit</td> <td>ER</td> <td>SSR4-CDG (CDG-Iy)</td> <td>XL</td> <td>24218363</td> </tr> <tr> <td class="subtitle2_left" colspan="7">N-glycan processing</td> </tr> <tr> <td class="indent1">Mannosyl-oligosaccharide glucosidase (<em>MOGS</em>)</td> <td>601336</td> <td>Alpha 1-2 glucosidase I (removes glucose from Glc3Man9GlcNAc2)</td> <td>ER</td> <td>MOGS-CDG (CDG-IIb)</td> <td>AR</td> <td>10788335</td> </tr> <tr> <td class="indent1">Glucosidase II alpha subunit (<em>GANAB</em>)</td> <td>104160</td> <td>Alpha 1-3 glucosidase II subunit alpha (removes last two glucose from Glc2Man9GlcNAc2)</td> <td>ER</td> <td>Polycystic kidney disease 3</td> <td>AD</td> <td>27259053</td> </tr> <tr> <td class="indent1">Protein kinase C substrate 80K-H (<em>PRKCSH</em>)</td> <td>177060</td> <td>Alpha 1-3 glucosidase II subunit beta (removes last two glucose from Glc2Man9GlcNAc2)</td> <td>ER</td> <td>Polycystic liver disease 1</td> <td>AD</td> <td>12529853, 12577059</td> </tr> <tr> <td class="indent1">Mannosidase alpha class 1B member 1 (<em>MAN1B1</em>)</td> <td>604346</td> <td>Alpha 1-2 mannosidase I (removes mannose from Man9GlcNAc2 and converting it to Man8GlcNAc2 isomer B)</td> <td>ER</td> <td>MAN1B1-CDG (MRT15)</td> <td>AR</td> <td>21763484</td> </tr> <tr> <td class="indent1">Mannosidase alpha class 2B member 2 (<em>MAN2B2</em>)</td> <td>618899</td> <td>Alpha 1-6 core-specific mannosidase (removes mannose from Man3GlcNAc2)</td> <td>Lysosomal</td> <td>MAN2B2-CDG</td> <td>AR</td> <td>31775018</td> </tr> <tr> <td class="indent1">Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (<em>MGAT2</em>)</td> <td>602616</td> <td>Beta 1-2 GlcNAc-transferase II (transfers N-acetylglucosamine to GlcNAcMan3GlcNAc2)</td> <td>Medial-Golgi</td> <td>MGAT2-CDG (CDG-IIa)</td> <td>AR</td> <td>8808595</td> </tr> <tr> <td class="indent1">Beta-1,4-galactosyltransferase 1 (<em>B4GALT1</em>)</td> <td>137060</td> <td>Beta 1-4 Gal-transferase (transfers galactose to either arm of GlcNAc2Man3GlcNAc2)</td> <td>Trans-Golgi</td> <td>B4GALT1-CDG (CDG-IId)</td> <td>AR</td> <td>11901181</td> </tr> <tr> <td class="indent1">Fucosyltransferase 8 (<em>FUT8</em>)</td> <td>602589</td> <td>Alpha 1-6 Fuc-transferase (adds core fucose)</td> <td>Golgi</td> <td>FUT8-CDG</td> <td>AR</td> <td>29304374</td> </tr> <tr> <td class="indent1">Fucose kinase (<em>FUK</em>)</td> <td>608675</td> <td>Fucokinase (converts L-fucose to fucose-1-phosphate)</td> <td>Cytosol</td> <td>FUK-CDG</td> <td>AR</td> <td>30503518</td> </tr> </tbody></table></div><div class="graphic_footnotes">AD: autosomal dominant; AR: autosomal recessive; CDG: congenital disorder of glycosylation; CMS: congenital myasthenic syndrome; EIEE: early infantile epileptic encephalopathy; ER: endoplasmic reticulum; Fru-6-P: fructose 6 phosphate; GlcNAc: N-acetylglucosamine; Man-1-P: mannose 1-phosphate; Man-6-P: mannose 6-phosphate; MRT: intellectual disability; OST: oligosaccharyltransferase; XL: X linked; XMEN: X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection, and neoplasia.</div><div class="graphic_reference">Adapted from: Ferreira CR, Altassan R, Marques-Da-Silva D, et al. Recognizable phenotypes in CDG. J Inherit Metab Dis 2018; 41:541.</div><div id="graphicVersion">Graphic 140151 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
